Supporting STEM2D professionals everywhere
At Johnson & Johnson, we aspire to be the employer of choice for women in STEM2D fields (Science, Technology, Engineering, Math, Manufacturing, and Design) because we believe diversity broadens viewpoints, allowing greater potential for new discoveries and innovations.
Expand
Collapse
![WiSTEM2D - Professionals Banner](https://jnj-content-lab2.brightspotcdn.com/dims4/default/8c851f7/2147483647/strip/true/crop/962x541+889+0/resize/1240x697!/quality/90/?url=https%3A%2F%2Fjnj-production-jnj.s3.us-east-1.amazonaws.com%2Fbrightspot%2F13%2F8d%2F27c0602403b2439eee9f2cd13782%2Fprofessionals-gettyimages-78779462.png)
Our mission
Igniting Women: We remain focused on inspiring, nurturing and recognizing groundbreaking female leaders. We believe women can be catalysts for creating healthier people, healthier communities and a healthier world.
![wistem lab 2](https://jnj-content-lab2.brightspotcdn.com/dims4/default/c5a0c9c/2147483647/strip/true/crop/4663x3494+0+173/resize/327x245!/quality/90/?url=https%3A%2F%2Fjnj-production-jnj.s3.us-east-1.amazonaws.com%2Fbrightspot%2Ff3%2F10%2F3dcdd8c0898c53259228bf31d332%2Fwistem-lab-2.jpg)
Supporting women at work
Johnson & Johnson named #1 on Working Mother‘s 100 Best Companies List
The company has appeared on the list for over three decades, and like years past, has nominated a Johnson & Johnson Working Mother of the Year.
Why WiSTEM2D matters to us
-
Johnson & Johnson was founded on science and innovation and we’re committed to being a partner and advocate for women. We are enthusiastic about working with esteemed institutions and organizations to expand the idea base in STEM2D fields and fostering diversified perspectives across the world.
Kathy WengelExecutive Vice President & Chief Global Supply Chain Officer
More from Johnson & Johnson
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
“I’m a scientist dedicated to bringing eye-health innovations to the world”
Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.